It is widely hypothesized that menstrual pain is triggered by prostaglandin synthesis that evokes high-pressure uterine contractions and ischemia. However, the effects of molecules implicated in menstrual pain on uterine contractility, perfusion, and oxygenation in vivo have been rarely demonstrated. Studies in women that do not respond to nonsteroidal anti-inflammatory drugs (NSAIDs) have reported elevated levels of platelet-activating factor (PAF). To establish in vivo evidence of PAF’s capability to impair uterine homeostasis and to elicit visceral pain, we examined the effects of the PAF receptor agonist (carbamyl PAF [CPAF]) in comparison to other molecules hypothesized to play a role in uterine pain in mice. Uterine pressure was increased by oxytocin, prostaglandin F2α (PGF2α), and CPAF. Even in the absence of inflammatory molecules, uterine contractions reduced uterine oxygenation by 38%. CPAF reduced uterine perfusion by 40% ± 8% and elicited further oxygen desaturation approaching hypoxia (9.4 ± 3.4 mm Hg Pao2). Intraperitoneal injections of CPAF and PGF2α evoked visceral pain and pelvic hyperalgesia in awake wild-type mice. However, pain was not observed in identically injected PAF-receptor knockout mice. Thus, our model provides a demonstration that a molecule implicated in NSAID-resistant dysmenorrhea has a detrimental effect on uterine homeostasis and is capable of causing visceral pain. Our results support the general hypothesis that menstrual cramps are caused by uterine contractions, impaired perfusion, and reduced oxygenation. Since this study was limited to mice, confirmation of these results in humans would be valuable for development of novel therapeutics targeted at inflammatory precursors, contractility, perfusion, and tissue oxygenation.
AnderschBMilsomI. An epidemiologic study of young women with dysmenorrhea. Am J Obstet Gynecol. 1982; 144(6): 655–660.
2.
ZondervanKTYudkinPLVesseyMP. Chronic pelvic pain in the community—symptoms, investigations, and diagnoses. Am J Obstet Gynecol. 2001; 184(6): 1149–1155.
3.
WestlingAMTuFFGriffithJWHellmanKM. The association of dysmenorrhea with noncyclic pelvic pain accounting for psychological factors. Am J Obstet Gynecol. 2013; 209(5): 422e1–422.e10.
4.
DawoodMY. Primary dysmenorrhea: Advances in pathogenesis and management. Obstet Gynecol. 2006; 108(2): 428–441.
5.
DeligeoroglouE. Dysmenorrhea. Ann N Y Acad Sci. 2000; 900: 237–244.
6.
ChanWY. Prostaglandins and nonsteroidal antiinflammatory drugs in dysmenorrhea. Annu Rev Pharmacol Toxicol. 1983; 23: 131–149.
7.
JacobGCostaFShannonJR. The neuropathic postural tachycardia syndrome. N Engl J Med. 2000; 343(14): 1008–1014.
8.
NigamSBenedettoCZoncaMLeo-RossbergILübbertHHammersteinJ. Increased concentrations of eicosanoids and platelet-activating factor in menstrual blood from women with primary dysmenorrhea. Eicosanoids. 1991; 4(3): 137–141.
9.
CaplanMSSimonDJillingT. The role of PAF, TLR, and the inflammatory response in neonatal necrotizing enterocolitis. Semin Pediatr Surg. 2005; 14(3): 145–151.
10.
VargaftigBBLefortJChignardMBenvenisteJ. Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives. Eur J Pharmacol. 1980; 65(2–3): 185–192.
11.
SimoniJSimoniGLoxCDMcGunegleDEFeolaM. Cytokines and PAF release from human monocytes and macrophages: Effect of hemoglobin and contaminants. Artif Cells Blood Substit Immobil Biotechnol. 1994; 22(3): 525–534.
12.
HemmingsRMironPFalconeTBourqueJLepageNLanglaisJ. Platelet-activating factor acetylhydrolase activity in peritoneal fluids of women with endometriosis. Obstet Gynecol. 1993; 81(2): 276–279.
13.
HasegawaSKohroYShiratoriM. Role of PAF receptor in proinflammatory cytokine expression in the dorsal root ganglion and tactile allodynia in a rodent model of neuropathic pain. PLoS One. 2010; 5(5): e10467.
14.
MontrucchioGAlloattiGTettaCRoffinelloCEmanuelliGCamussiG. In vitro contractile effect of platelet-activating factor on guinea-pig myometrium. Prostaglandins. 1986; 32(4): 539–554.
15.
MedeirosYSCalixtoJB. Effect of PAF-acether on the reactivity of the isolated rat myometrium. Braz J Med Biol Res. 1989; 22(9): 1131–1135.
16.
WoodburyRATorpinR. Myometrial physiology and its relation to pelvic pain. J Am Med Assoc. 1947; 134(13): 1081–1085.
17.
DmitrovicRKunselmanARLegroRS. Sildenafil citrate in the treatment of pain in primary dysmenorrhea: A randomized controlled trial. Hum Reprod. 2013; 28(11): 2958–2965.
18.
MitchellJAYochimJM. Intrauterine oxygen tension during the estrous cycle in the rat: Its relation to uterine respiration and vascular activity. Endocrinology. 1968; 83(4): 701–705.
19.
GarrisDRMitchellJA. Intrauterine oxygen tension during the estrous cycle in the guinea pig: Its relation to uterine blood volume and plasma estrogen and progesterone levels. Biol Reprod. 1979; 21(1): 149–159.
20.
FischerBBavisterBD. Oxygen tension in the oviduct and uterus of rhesus monkeys, hamsters and rabbits. J Reprod Fertil. 1993; 99(2): 673–679.
21.
NordsmarkMLoncasterJChouSC. Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma. Int J Radiat Oncol Biol Phys. 2001; 49(2): 581–586.
22.
JankovicBAquino-ParsonsCRaleighJA. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix. Cytometry B Clin Cytom. 2006; 70(2): 45–55.
23.
CoudyzerPLemoinePJordanBF. Hypoxia is not required for human endometrial breakdown or repair in a xenograft model of menstruation. FASEB J. 2013; 27(9): 3711–3719.
24.
ZimmermannM. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983; 16(2): 109–110.
25.
IshiiSKuwakiTNagaseT. Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor. J Exp Med. 1998; 187(11): 1779–1788.
GebhartGFSenguptaJN. Evaluation of Visceral Pain. In: Handbook of methods in gastrointestinal pharmacology. 1995: 359–374.
28.
YooKYLeeJCYoonMH. The effects of volatile anesthetics on spontaneous contractility of isolated human pregnant uterine muscle: A comparison among sevoflurane, desflurane, isoflurane, and halothane. Anesth Analg. 2006; 103(2): 443–447, table of contents.
29.
ChildGPWoodburyRA. Cyclic changes in human uterine pressure curves and the influence of distention and pitressin upon these curves. Fed Proc. 1947; 6(1): 316.
30.
JoelssonIGidlundLAnzénBIngelman-SundbergA. In vivo determination of the stress-strain relation of the human myometrium. Acta Obstet Gynecol Scand. 1976; 55(4): 325–331.
31.
BerkleyKJWoodEScofieldSLLittleM. Behavioral responses to uterine or vaginal distension in the rat. Pain. 1995; 61(1): 121–131.
32.
NasuKNaraharaHMatsuiNKawanoYTanakaYMiyakawaI. Platelet-activating factor stimulates cytokine production by human endometrial stromal cells. Mol Hum Reprod. 1999; 5(6): 548–553.
33.
TerashitaZImuraYTakataniMTsushimaSNishikawaK. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo. J Pharmacol Exp Ther. 1987; 242(1): 263–268.
34.
LumsdenMAKellyRWBairdDT. Primary dysmenorrhoea: The importance of both prostaglandins E2 and F2 alpha. Br J Obstet Gynaecol. 1983; 90(12): 1135–1140.
35.
ChristophTGrünwellerAMikaJ. Silencing of vanilloid receptor TRPV1 by RNAi reduces neuropathic and visceral pain in vivo. Biochem Biophys Res Commun. 2006; 350(1): 238–243.
36.
Lantéri-MinetMBonKde PommeryJMichielsJFMenétreyD. Cyclophosphamide cystitis as a model of visceral pain in rats: Model elaboration and spinal structures involved as revealed by the expression of c-Fos and Krox-24 proteins. Exp Brain Res. 1995; 105(2): 220–232.
37.
OhlssonL. Algesimetric studies by the hot plate method in mice. Acta Pharmacol Toxicol (Copenh). 1953; 9(4): 322–331.
38.
WesselmannULaiJ. Mechanisms of referred visceral pain: Uterine inflammation in the adult virgin rat results in neurogenic plasma extravasation in the skin. Pain. 1997; 73(3): 309–317.
39.
ChildressCHKatzVL. Nifedipine and its indications in obstetrics and gynecology. Obstet Gynecol. 1994; 83(4): 616–624.
40.
TeatherLAMagnussonJEWurtmanRJ. Platelet-activating factor antagonists decrease the inflammatory nociceptive response in rats. Psychopharmacology (Berl). 2002; 163(3–4): 430–433.
41.
FrieseNDiopLChevalierEAngelFRivièrePJDahlSG. Involvement of prostaglandins and CGRP-dependent sensory afferents in peritoneal irritation-induced visceral pain. Regul Pept. 1997; 70(1): 1–7.
42.
MotoyamaNMoritaKKitayamaT. Pain-releasing action of platelet-activating factor (PAF) antagonists in neuropathic pain animal models and the mechanisms of action. Eur J Pain. 2013; 17(8): 1156–1167.
43.
AhmedADearnSShamsM. Localization, quantification, and activation of platelet-activating factor receptor in human endometrium during the menstrual cycle: PAF stimulates NO, VEGF, and FAKpp125. FASEB J. 1998; 12(10): 831–843.
44.
GuilbaudGBerkleyKJBenoistJMGautronM. Responses of neurons in thalamic ventrobasal complex of rats to graded distension of uterus and vagina and to uterine suprafusion with bradykinin and prostaglandin F2 alpha. Brain Res. 1993; 614(1–2): 285–290.
45.
MurrayWJMillerJW. Oxytocin-induced “cramping” in the rat. J Pharmacol Exp Ther. 1960; 128: 372–379.
46.
YangLCaoZYuBChaiC. An in vivo mouse model of primary dysmenorrhea. Exp Anim. 2015; 64(3): 295–303.
47.
LemancewiczAUrbanRSkotnickiMZKarpiukAUrbanJ. Uterine and fetal Doppler flow changes after misoprostol and oxytocin therapy for induction of labor in post-term pregnancies. Int J Gynaecol Obstet. 1999; 67(3): 139–145.
48.
RotmenschSLiberatiMCelentanoCBellatiUTiboniGMBen-RafaelZ. Doppler velocimetry of the uterine and fetal circulations during prostaglandin E2 cervical ripening. Ultrasound Obstet Gynecol. 1996; 8(5): 333–336.
49.
O’FlahertyJTRedmanJFSchmittJD. 1-O-alkyl-2-N-methylcarbamyl-glycerophosphocholine: A biologically potent, non-metabolizable analog of platelet-activating factor. Biochem Biophys Res Commun. 1987; 147(1): 18–24.
50.
CardileVMascarucciPDe SimoniMGJiangXBindoniM. The effect of ether lipid 1-O-octadecyl-2-O-methoxy-rac-glycero-3-phosphocholine and its analogues platelet activating factor and carbamyl-platelet activating factor on the biosynthesis of interleukin-6 in human thymic epithelial cells cultivated in vitro. Cytokine. 1996; 8(9): 698–701.
51.
CardileVJiangXRenisMBindoniM. Effects of ether lipid 1-O-octadecyl-2-methoxy-rac-glycero-3-phosphocholine and its analogs PAF and CPAF on the release of nitric oxide in primary cultures of rat astrocytes. Brain Res. 1996; 715(1–2): 98–103.
52.
YasudaKOkumuraTOkadaH. Platelet-activating factor acetylhydrolase isoforms I and II in human uterus. Comparisons with pregnant uterus and myoma. Biol Reprod. 2001; 64(1): 339–344.
53.
IacovidesSAvidonIBakerFC. What we know about primary dysmenorrhea today: A critical review. Hum Reprod Update. 2015; 21(6): 762–778.
54.
KidoAKoyamaTKataokaM. Physiological changes of the human uterine myometrium during menstrual cycle: Preliminary evaluation using BOLD MR imaging. J Magn Reson Imaging. 2007; 26(3): 695–700.
55.
KaufmanDLMitchellJA. Intrauterine oxygen tension during the oestrous cycle in the hamster: Patterns of change. Comp Biochem Physiol Comp Physiol. 1994; 107(4): 673–678.
56.
JordanBFKimpalouJZBegheinNDessyCFeronOGallezB. Contribution of oxygenation to BOLD contrast in exercising muscle. Magn Reson Med. 2004; 52(2): 391–396.
57.
JarmTLesnicarHSersaGMiklavcicD. First experience with a novel luminescence-based optical sensor for measurement of oxygenation in tumors. Radiol Oncol. 2001; 35(4): 277–292.
58.
Larcombe-McDouallJButtellNHarrisonNWrayS. In vivo pH and metabolite changes during a single contraction in rat uterine smooth muscle. J Physiol. 1999; 518(Pt 3): 783–790.
59.
JouppilaRHollménA. The effect of segmental epidural analgesia on maternal and foetal acid-base balance, lactate, serum potassium and creatine phosphokinase during labour. Acta Anaesthesiol Scand. 1976; 20(3): 259–268.
60.
KaldBKaldAIhseITagessonC. Release of platelet-activating factor in acute experimental pancreatitis. Pancreas. 1993; 8(4): 440–442.
KaranjiaNDReberHA. The cause and management of the pain of chronic pancreatitis. Gastroenterol Clin North Am. 1990; 19(4): 895–904.
63.
ChauhanSForsmarkCE. Pain management in chronic pancreatitis: A treatment algorithm. Best Pract Res Clin Gastroenterol. 2010; 24(3): 323–335.
64.
DrosteCRoskammH. Experimental pain measurement in patients with asymptomatic myocardial ischemia. J Am Coll Cardiol. 1983; 1(3): 940–945.
65.
RobinsonBF. Relation of heart rate and systolic blood pressure to the onset of pain in angina pectoris. Circulation. 1967; 35(6): 1073–1083.
66.
DeanfieldJEMaseriASelwynAP. Myocardial ischaemia during daily life in patients with stable angina: Its relation to symptoms and heart rate changes. Lancet. 1983; 2(8353): 753–758.
67.
TsudaMIshiiSMasudaT. Reduced pain behaviors and extracellular signal-related protein kinase activation in primary sensory neurons by peripheral tissue injury in mice lacking platelet-activating factor receptor. J Neurochem. 2007; 102(5): 1658–1668.
68.
PotterPMasperoJFVermeulenJ. Rupatadine oral solution in children with persistent allergic rhinitis: A randomized, double-blind, placebo-controlled study. Pediatr Allergy Immunol. 2013; 24(2): 144–150.
69.
KingsnorthANGallowaySWFormelaLJ. Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis. Br J Surg. 1995; 82(10): 1414–1420.
